| Name | Title | Contact Details |
|---|
Implant Direct, LLC is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
EXAKT Technologies is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sensiotec Inc., a medical device company, designs and delivers non-contact remote vital signs monitoring solutions in the United States. The company offers Virtual Medical Assistant that monitors patients, supporting evidenced-based medicine; and monitors heart and respiration rates and movement without pressure pads, sensors, or cuffs that touch the patient. The company serves acute and subacute care facilities, which include hospitals, surgery centers, outpatient clinics, skilled nursing, long-term care and hospice facilities. Sensiotec Inc. was founded in 2008 and is based in Atlanta, Georgia.
Sorenson BioScience is a manufacturer of disposable plastic liquid handling products. Located in Salt Lake City, Utah, it was founded in 1981 as Mµlti Technology, Inc. The company rapidly became an innovator in the manufacture of liquid handling products
TearLab Corporation develops and commercializes lab-on-a-chip technologies that enable eye care practitioners to improve standard of care by quantitatively testing for disease markers in tears at the point-of-care. Headquartered in San Diego, CA, TearLab Corporation`s common shares trade on the NASDAQ Capital Market under the symbol `TEAR` and on the Toronto Stock Exchange under the symbol `TLB`. Dry Eye Disease (DED) is a chronic, progressive disease. Morgan Stanley’s Dry Eye Market Report (2003) estimates that 30 to 60 million Americans suffer from dry eye symptoms. Only 10 million are diagnosed with the disease. Millions more suffer worldwide. The TearLab™ Osmolarity System provides the first quantitative and objective diagnostic technology that allows doctors to effectively manage their dry eye patients. TearLab will allow practitioners to diagnosis DED patients early in the disease process allowing for early intervention. TearLab received the CE Mark for its TearLab Osmolarity System in 2008 and FDA Clearance in 2009. TearLab is currently marketed globally in more than 14 countries including the US.